Epidemiological models are routinely used to predict the effects of interventions aimed at 20 reducing the impacts of Ebola epidemics. Most models of interventions targeting 21 symptomatic hosts, such as isolation or treatment, assume that all symptomatic hosts are 22 equally likely to be detected. In other words, following an incubation period, the level of 23 symptoms displayed by an individual host is assumed to remain constant throughout an 24 infection. In reality, however, symptoms vary between different stages of infection. During 25 an Ebola infection, individuals progress from initial non-specific symptoms through to 26 more severe phases of infection. Here we compare predictions of a model in which a 27 constant symptoms level is assumed to those generated by a more epidemiologically 28 realistic model that accounts for varying symptoms during infection. Both models can 29 reproduce observed epidemic data, as we show by fitting the models to data from the 30 ongoing epidemic in the Democratic Republic of Congo and the 2014-16 epidemic in 31 Liberia. However, for both of these epidemics, when interventions are altered identically 32 in the models with and without levels of symptoms that depend on the time since first 33 infection, predictions from the models differ. Our work highlights the need to consider 34 whether or not varying symptoms should be accounted for in models used by decision 35 makers to assess the likely efficacy of Ebola interventions. 36 37
INTRODUCTION 42 43
Ebola epidemics have devastating consequences. The current epidemic in the To show that our results are not conditioned on particular properties of data from a 112 single epidemic, we conducted two separate analyses in which we considered data from 113 two different Ebola epidemics. 114
115
In the first analysis, we used data on the numbers of cases in approximately weekly 116 time intervals from the ongoing Ebola epidemic in the Democratic Republic of Congo. It 117 has recently been suggested by Dr Peter Salama, Deputy Director-General of 118
Emergency Preparedness and Response at the World Health Organization, that this 119
epidemic comprises several distinct outbreaks in different affected areas. Indeed, 120 disease incidence time series display distinct phases (large numbers of cases at the 121 end of July/beginning of August 2018, followed by low numbers of cases in September, 122
and then larger numbers of cases again thereafter), probably due to spatial effects of 123 spread of the virus which are not captured by standard non-spatial compartmental 124 models [15] . For this reason, we focussed on data from the health zone of Beni, a city in 125 the north-east of the Democratic Republic of Congo, and the neighbouring health zone 126 of Kalunguta. This region has been severely impacted by the current epidemic. These 127 data were obtained from World Health Organization disease outbreak news reports from 128 4 th August 2018 to 10 th January 2019 (Data S1, see also [16] ). 129
In the second analysis, we considered data comprising of the numbers of cases in 131 approximately weekly time intervals in Liberia during the 2014-16 Ebola epidemic, which 132 were obtained from the World Health Organization (Data S2, see also [17] ). 133
134

Mathematical model 135 136
In the commonly used SEIR model, individuals are classified according to whether they 137 are (S)usceptible to infection, (E)xposed, (I)nfected by the pathogen or (R)emoved andno longer infectious. We extended this model to account explicitly for case finding 139 followed by isolation of infectious individuals. We also assumed that there were three 140 distinct phases of infection, corresponding to different stages of an Ebola infection. This 141 delivered the additional benefit that the infectious period (in the absence of control) was 142 gamma distributed, rather than exponentially distributed -and gamma distributions 143 have been found to characterise epidemiological periods accurately in a range of 144 systems [18, 19] . This gave rise to the SEI1I2I3RC model, 145
In this model, the C compartment represents the number of individuals that have ever 155 been controlled (detected and isolated) until the current time. Since we wish to isolate 156 the impacts on prediction of variable symptoms alone, in the baseline version of the 157 model we assume that all infectious hosts are equally infectious -although we consider 158 the effect of relaxing this assumption later. 159
160
In our analyses, we made the assumption widely used in Ebola models that the infection 161 rate parameter in the model is temporally-varying [4, 5] , to reflect changes in 162 transmissibility during the epidemic. This could, for example, indicate changes in 163 behavioural responses or alterations to interventions (aside from detection and isolation, 164 since we model that explicitly). In particular, we assumed that 165 ( ) = 8 9 for ≤ days, * for > days.
We then considered two alternative versions of the model. In the first (the constant 169 symptoms model -Fig 2A) , we assumed that all infectious individuals are successfully 170 detected and isolated at the same average rate per day, so that δ * = δ , = δ -= δ, say. 171
This assumption is common to any epidemiological model that includes interventions 172 aimed at symptomatic hosts, unless differences in symptom expression are accounted 173 for explicitly. The constant symptoms model is therefore similar to most epidemiological 174 models that have been used to represent Ebola epidemics previously (e.g. [4, 13] ). 175
176
We also considered the more realistic case in which symptoms become more severe as 177 infection progresses, so that δ * < δ , < δ -. We refer to the resulting model as the 178 variable symptoms model (Fig 2B) . This model reflects the fact that, in reality, 179 individuals with initial mild symptoms are less likely to be detected and isolated to 180 prevent further transmission than individuals with more developed symptoms who are in 181 the gastrointestinal or deterioration phases. 182 assumed to intensify during an Ebola infection (so that the detection rate is smaller for individuals in earlier 187 infection compared to later infection, i.e. δ * < δ , < δ -). We also show how additional epidemiological 188 complexity can be included in these models (see Supplementary Material).
190
Model fitting and parameters 191 192
We considered the numerical solutions of the models described above in a host 
197
The default parameter values used in our analyses are given in The values of the parameters characterising the rate of Ebola detection and isolation, 211
i.e. δ * , δ , and δ -, depend on the level of surveillance, which includes various passive 212 and active case finding strategies. We did not model explicitly the wide range of 213 different surveillance activities that take place during an Ebola response (see 214 Discussion). However, to provide a concrete setting in which to illustrate the principle 215 that forecasts are different under the constant symptoms and variable symptoms 216 models, we instead considered a simplified scenario in which each host is checked for 217 infection on average every ∆ days. Each time monitoring occurs, there is a detection 218 probability of J for individuals in class J (for = 1,2, or 3). As a result, 219
This expression is derived in the Supplementary Material (for a similar approach, see 223
also [20]). 224 225
In our main analyses, we considered two different surveillance regimes. When the 226 models were fitted, under weak surveillance, we assumed that the default surveillance 227 period was ∆ = 21 days. When the fitted models were then used to predict the impacts 228 of intensified surveillance, the surveillance period was changed to ∆ = 14 days. We 229 assumed that the detection probability in the constant symptoms model was * = , = 230 -= 0.6. When we accounted for the possibility that symptoms change as hosts 231 progress through infection, we instead used default values of * = 0.1, , = 0.8 and 232 -= 0.9 so that the mean value of * , , and -was equal to the value of these 233 parameters in the constant symptoms model. In other words, conditional on not being 234 detected previously, a host chosen at a random time in the infectious period was equally 235 likely to be detected in both models. 236 237
RESULTS 238 239
As described in the Introduction, fitted models are often used to test potential control 240 interventions (Fig 1) . We therefore considered fitting models to two different datasets -241 one from the current Ebola epidemic in the Democratic Republic of Congo, and another 242 from the historical Ebola epidemic in west Africa in 2014-16. 243 244 First, we considered data from the ongoing Ebola epidemic in the Democratic Republic 245 of Congo (Fig 3A) . We fitted the constant symptoms model and variable symptoms 246 model to these data in turn, and found that both of these models could replicate the 247 observed dynamics of the epidemic (Figs 3B). We then used these fitted models to 248 predict how the epidemic dynamics would have been altered under a different control 249 intervention. In particular, we increased the rate of detection in the fitted models, to 250 represent predictions under an intensification of surveillance and control efforts (see 251
Methods). 252 253
When surveillance was intensified, the prediction of the constant symptoms model 254 differed substantially from that of the variable symptoms model (Fig 3C) . In particular, 255
for the parameter values displayed here, the constant symptoms model predicted 24% 256 fewer cases than the more epidemiologically realistic variable symptoms model (108 257 cases in the constant symptoms model as opposed to 142 cases in the variable 258 symptoms model). Consequently, even though the observed dynamics of the modelsappear identical when fitted to data, they produce different predictions when control 260 interventions are changed. 261
We then repeated our analysis, instead using data from the 2014-16 Ebola epidemic in 263 west Africa (Figs 3D-F). In this case, the constant symptoms model predicted 35% 264 fewer cases than the variable symptoms model (Fig 3F) . Since the total number of 265 cases in this epidemic was so large, this corresponded to 641 cases difference between 266 the forecasts of the two models. 267
268
We also considered the robustness of our results to the values of the model 269 parameters, including the level of surveillance assumed when fitting to data and the 270 extent to which surveillance was intensified in the models (Figs S1-S7). In addition, we 271 considered different values of the detection probability whenever surveillance occurs 272 (Figs S8 and S9). In each case, we found qualitatively identical results -both the 273 constant symptoms and variable symptoms models could reproduce epidemic time 274 series data, but when interventions were changed in the models the predicted epidemic 275 dynamics then differed. As well as considering an intensification of surveillance, we also 276 examined cases in which surveillance was relaxed (e.g. Figs S4B and S4C ). Whenever 277 surveillance was intensified, the constant symptoms model underestimated the total 278 number of cases compared to the more realistic variable symptoms model. However, 279 when surveillance was instead reduced, the constant symptoms model led to 280 overestimation of the total number of cases. 281
282
We also considered the effect of enhancing surveillance at different times during the 283 epidemic. In particular, we considered increasing the surveillance level once the 284 epidemics had already been in progress until a certain date, for different possible dates 285 of surveillance intensification. The earlier that surveillance was intensified, the larger the 286 error when using the constant symptoms model rather than the more biologically 287 realistic variable symptoms model, since early surveillance intensification then allows 288 more time for model predictions to differ (Figs 4 and S10). 289
Until this point, so that we could isolate the effect of variable symptoms alone on the 291 predicted outcomes of interventions, we assumed that at any time during an epidemic 292 all infected and uncontrolled hosts generated new infections at a constant rate. 293 However, we also conducted an analysis in which the infection rate also varied 294 throughout the course of an Ebola infection, by considering cases in which 295 infectiousness was either correlated with or correlated against the level of symptom 296 expression (Fig 5 and Supplementary Material) . In cases in which higher levels of 297 symptoms were associated with reduced infectiousness -for example due to a lower 298 level of mixing in the population compared to hosts with less serious symptoms -our 299 result that predictions are different between the constant symptoms and variable 300 symptoms models was enhanced (Figs 5B and 5D). 
333
Predictions of the effect of intensified surveillance using the constant symptoms model (blue) and variable and assuming that infectiousness decreases during an Ebola infection as described in the Supplementary epidemics and the times at which the infection rates change), are identical to those described in Tables 1   339   and Here, we have considered Ebola virus disease as a case study, and used two models to 357 predict the possible effects on the dynamics of two epidemics under different 358 surveillance levels. We assumed that increased surveillance leads to improved 359 detection and control of symptomatic hosts. We compared the output of a model in 360 which, if an individual is surveyed, the probability of detection is constant at each time 361 during the infectious period (the constant symptoms model) to the equivalent predictions 362 from a model in which the probability of detection increases throughout infection (the 363 variable symptoms model). We found that both these models can be fitted closely to 364 data from Ebola epidemics (Figs 3B and 3E ). However, when the level of surveillance in 365 the models is increased, we found that the more epidemiologically realistic variablesymptoms model predicted a smaller number of cases (e.g. Figs 3C and 3F) consider a model of plant disease epidemics in which the rate of sporulation (production 380 of viable spores by each infected host) is a function of the time since infection, and 381 implement this in an SEIR model by splitting the E and I classes into compartments and 382 assigning different infection rates to hosts in the different I classes. A similar modelling 383 framework could be adopted in our work, using a large number of compartments so that 384 the level of symptoms is represented by a continuous curve (rather than being at 385 constant levels within the different stages of infection). However, we do not pursue this 386 here, since discrete changes in symptom expression in each symptomatic host are 387 sufficient to make our underlying point that accurate forecasts of the effects of Ebola 388 interventions may require models that account for variations in symptoms. We parameterised our models using the simplest possible approach -namely fitting the 421 numbers of detected or removed individuals in the relevant classes of the models to 422 data on the cumulative numbers of symptomatic cases using least squares estimation. 423
We did not quantify the uncertainty in estimates of the values of model parameters, 424 since the precise method of parameter inference was not central to our message. 425
Instead, we sought to use the simplest possible fitting method. While this approach is 426 used frequently during epidemics due to its ability to produce quick forecasts [5, 36, 37] ,to properly quantify the uncertainty in forward projections it would be necessary to use 428 non-cumulative incidence data and fit stochastic transmission models [38] . 429
430
One advantage of the models that we used is that the surveillance level is assumed to 431 impact on the epidemiological dynamics themselves, rather than simply the observed 432 dynamics. This is not always the case in epidemiological models: a common method for 433 accounting for under-reporting is simply to scale the incidence data up [39], thereby 434 assuming a fixed percentage of infectious cases are detected with no impact on the 435 numbers of cases generated by those individuals. Another approach is to assume that 436 some individuals in the infectious class are unobserved [40] . In reality, detected hosts 437 have a lower probability of transmitting the pathogen than undetected hosts due to the 438 higher chance that those individuals are subject to interventions, and our models reflect 439
this. 440 441
Here, we considered a control strategy of detection and isolation under different 442 surveillance levels. The effects of including variable symptoms in models of other 443 intervention strategies should be tested, to see whether it is always necessary to 444 account for changing levels of symptoms throughout infection. We note that including 445 additional epidemiological detail in forecasting models does not always improve 446 predictions [12] . Simple models are easier to parameterise and interpret than more 447 complex models, and so modellers should consider carefully, in each study, whether or 448 not including variable symptoms will change model predictions. We also note that, in 449 theory, it might be possible to deploy commonly used epidemiological models with 450 altered parameter values as a proxy for explicit consideration of variable symptoms [41] . Estimating the future number of cases in the Ebola epidemic -Liberia and Sierra 578 
